Related Experiment Videos
Photodynamic therapy in cholangiocarcinomas
1Department for Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, Lausanne CH 1011, Switzerland. maria-anna.ortner@hospyd.ch
Summary
Photodynamic therapy (PDT) offers a promising palliative option for advanced cholangiocarcinoma, improving survival and quality of life. Early surgical consultation remains crucial to identify curative options before palliative treatment.
Area of Science:
- Oncology
- Gastroenterology
- Medical Therapeutics
Background:
- Cholangiocarcinoma often presents with late-stage symptoms, limiting surgical candidacy to about 50% of patients.
- Palliative treatment options for advanced, non-resectable cholangiocarcinoma are limited, with endoprostheses offering only symptomatic relief for cholestasis.
- Current treatments like radiotherapy and chemotherapy lack robust evidence from randomized trials for improved survival in this patient group.
Purpose of the Study:
- To evaluate the efficacy and tolerability of photodynamic therapy (PDT) as a palliative treatment for non-resectable cholangiocarcinoma.
- To assess the impact of PDT on survival rates and quality of life in patients with advanced cholangiocarcinoma.
- To emphasize the importance of comprehensive staging and surgical consultation prior to initiating palliative measures.
Main Methods:
- Review of prospective, single-arm phase II trials and a randomized trial investigating photodynamic therapy (PDT).
- Analysis of treatment outcomes, including survival benefit and quality of life, in patients with non-resectable cholangiocarcinoma.
- Assessment of PDT's side-effect profile and patient tolerability.
Main Results:
- Photodynamic therapy (PDT) has shown encouraging results, indicating a considerable benefit in survival and improved quality of life for patients with non-resectable cholangiocarcinoma.
- PDT is generally well-tolerated, with a limited number of specific side-effects, making it suitable for patients with a short life expectancy.
- Despite promising palliative options like PDT, a thorough staging and surgical consultation are essential to rule out any possibility of curative surgery.
Conclusions:
- Photodynamic therapy (PDT) should be considered a viable palliative treatment option for all patients diagnosed with non-resectable cholangiocarcinoma.
- The benefits of PDT in terms of survival and quality of life, coupled with its good tolerability, support its recommendation.
- Prioritizing surgical consultation and staging is critical to ensure patients are not denied potentially curative surgical interventions.